FDA/OHRP Harmonization and Your HRPP Operations
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Institution
Full Board vs Expedited vs Exempt: Why IRBs do That
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Is Your Site Ready for an FDA Inspection?
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
How to Optimize Your sIRB Experience
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Rare and Orphan Diseases in Regulated Development
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Why Now is the Right Time to Adopt eConsent
eConsent streamlines trial participation, allowing remote access and minimizing paperwork errors, benefitting both research staff and participants alike.
Addressing Decentralized Pre-Enrollment Challenges for Sites and Site Networks
Addressing Decentralized Pre-Enrollment Challenges for Sites and Site Networks With continued consolidation and a move to decentralization in the research
Budget Negotiation 101
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Onboarding & Training for Clinical Research Professionals
In this webinar, Miranda Schramm, Director of Training at Advarra, covers strategies for new hires joining the clinical trial industry.
Didn’t Expect That to Happen: Events That Must be Reported Promptly to the IRB
Learn what events need to be reported to the IRB after study approval and explore scenarios to help evaluate potentially reportable events.
Increasing Diversity, Equity, and Access in Clinical Research: A Case Study
In the evolving landscape of clinical research, increasing diversity, equity, and access has become a pressing priority. A Clinical
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor?
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor? Attaining a diverse trial patient population is crucial to